9/30/2010

Mersana Therapeutics has selected Nicholas Bacopoulos, a biotech industry veteran who has been on the company's board since 2007, to serve as its president and chief executive. The company, which uses a bio-inert polymer technology in drug development, also has appointed its former CEO Julie Olson as chief technology officer.

Related Summaries